Dynavax Technologies Corp

Visual Financials
Company Name: Dynavax Technologies Corp
Ticker Symbol: DVAX
CIK Number: 0001029142
WWW Address: http://www.dynavax.com
CEO: Eddie Gray
No. of Employees: 251
Common Issue Type: CS
Business Description:Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 3.98 Unchanged 0.0 3.53 4.1  4.72 4.15 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 259.0 65.1 0.00 -2.55 0.00 0.0 0.0 16.65 - 4.15
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close4.20$
PE Ratio - LTM0.0
Market Capitalisation259.0mil
Latest Shares Outstanding65.1mil
Earnings pS (EPS)-2.55$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee32,924$
Effective Tax Rate0.0%
Float62.5mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue7.90%
Research & Devlopment (R&D) as % of Revenue9.10%
Gross Profit Margin-165.9%
EBITDA Margin-1647.7%
Pre-Tax Profit Margin0.0%
Assets Turnover3.8%
Return on Assets (ROA)-74.0%
Return on Equity (ROE)-121.0%
Return on Capital Invested (ROCI)-66.1%
Current Ratio4.6
Leverage Ratio (Assets/Equity)3.3
Interest Cover-16.0
Total Debt/Equity (Gearing Ratio)1.60
LT Debt/Total Capital62.0%
Working Capital pS2.10$
Cash pS0.05$
Book-Value pS0.66$
Tangible Book-Value pS0.76$
Cash Flow pS-2.25$
Free Cash Flow pS-2.50$
KEY FIGURES (LTM): Price info
Price/Book Ratio8.71
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----12.91,877,0976,287,893
4 Weeks8.194.157.89-46.81,488,65228,284,388
13 Weeks9.234.158.34-49.61,144,30272,091,045
26 Weeks12.424.1510.54-60.21,107,307137,306,088
52 Weeks16.654.1515.70-73.21,074,088268,522,034
YTD12.424.15--55.61,096,937118,469,222
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
4.565.066.478.919.820.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue-0.062.50.26
Income0.0
Dividend0.0
Capital SpendingNA
R&D-0.84NA4.95
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-11.3-11.3-55.1
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.000.00-0.02
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio64.65
Current Ratio4.6
Quick Ratio (Acid Test)3.9
Liquidity Ratio (Cash)5.12
Receivables Turnover3.6
Average Collection Period100
Working Capital/Equity216.2
Working Capital pS2.13
Cash-Flow pS-2.11
Free Cash-Flow pS-2.35
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-2.62
Financial Leverage Ratio (Assets/Equity)1.6
Debt Ratio47.8
Total Debt/Equity (Gearing Ratio)1.60
LT Debt/Equity1.60
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities100.0
Interest Cover-16.0
Interest/Capital Invested14.81
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.78
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-1.34
Enterprise Value (EV)/Free Cash Flow-1.29
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM8.71
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS1.65
Current Liabilities pS0.62
Tangible Book Value pS - LTM0.76
Book Value pS - LTM0.66
Capital Invested pS2.52
Cash pS - LTM0.05
Cash Flow pS - LTM-2.25
Free Cash Flow pS - LTM-2.50
Earnings pS (EPS)-2.55
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-1,786.87
Free Cash Flow Margin 5YEAR AVG-5,975.59
Net Profit Margin-19.4
Net Profit Margin - 5YEAR AVRG.-71.0
Equity Productivity0.13
Return on Equity (ROE)-1.2
Return on Equity (ROE) - 5YEAR AVRG.-0.8
Capital Invested Productivity0.05
Return on Capital Invested (ROCI)-0.7
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.7
Assets Productivity0.00
Return on Assets (ROA)-0.7
Return on Assets (ROA) - 5YEAR AVRG.-0.6
Gross Profit Margin-165.9
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM-1647.7
EBIT Margin - LTM-1824.4
Pre-Tax Profit Margin-71.0
Pre-Tax Profit Margin - 5YEAR AVRG.-71.0
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee32,924
Net Income per Employee
Average Collection Period
Receivables Turnover3.6
Day's Inventory Turnover Ratio
Inventory Turnover2.3
Inventory/Sales232.0
Accounts Payble/Sales64.38
Assets/Revenue0.00
Net Working Capital Turnover0.06
Fixed Assets Turnover0.22
Total Assets Turnover0.0
Revenue per $ Cash2.61
Revenue per $ Plant0.48
Revenue per $ Common Equity0.13
Revenue per $ Capital Invested0.05
Selling, General & Adm/tive (SG&A) as % of Revenue790.1
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue914.3
R&D Expense as % of Revenue - 5YEAR AVRG.914.3

  


Your Recent History
NASDAQ
DVAX
Dynavax Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.